Health Care
Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call
Aurora Cannabis (ACB) on Monday reported a loss of C$238 million in the second quarter of 2019, compared to a…
Aurora Cannabis reports a loss of C$238 million for Q2
After a long delay, Aurora Cannabis (ACB) reported its second quarter 2019 results. The company reported a loss of C$238 million…
Four cheap biotech stocks to buy
In the current environment, investment in the biotech stocks could be a risky recommendation for the investors. Despite its erratic…
Tilray (TLRY) is reporting Q4 earnings results on March 18. What you need to know
Canadian cannabis giant Tilray (TLRY) is scheduled to report fourth-quarter earnings results on Monday, March 18. Analysts expect the company,…
Earnings Preview: Positive sentiment around Teva
Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report fourth-quarter 2018 earnings results on Wednesday, February 13, before market open.…
Aurora Cannabis Q2 Earnings: Will the shopping spree continue?
Marijuana giant Aurora Cannabis (ACB) is scheduled to report its Q2 earnings on Monday after the bell. Last month, the…
IPO update: Two healthcare unicorns went public this week
We had earlier reported on why 2018 was the year of healthcare IPOs. It seems the trend is continuing into…
ImmunoGen reports Q4 loss; stock gains as results beat estimates
Biotechnology firm ImmunoGen Inc. (IMGN) reported a wider net loss for the fourth quarter, hurt by a sharp fall in…
ImmunoGen Q4 Earnings Preview: All eyes on FORWARD trial update
ImmunoGen (NASDAQ: IMGN) is slated to report its fourth quarter 2018 results tomorrow before the bell. The most anticipated update…
Cardinal Health stock surges above 6% on Q2 earnings beat
Cardinal Health (NYSE: CAH) reported better-than-expected Q2 results primarily driven by better performance from the Pharmaceutical division. The company’s stock…
Regeneron Q4 profit soars 371%, beats estimates
Regeneron Pharmaceuticals Inc. (REGN) reported a 371% jump in earnings for the fourth quarter helped by higher product sales and…
Boston Scientific Q4 earnings beat on strong sales growth; stock moves up
Broad-based sales growth, marked by a double-digit increase in emerging markets, lifted Boston Scientific’s (BSX) fourth-quarter earnings, which surpassed the…
Humana’s stock gains as Q4 results top expectations
Humana Inc. (HUM) topped analysts’ expectations on revenue and earnings for the fourth quarter of 2018. Shares inched up slightly…
Eli Lilly Q4 profit misses estimates, cuts 2019 outlook
Eli Lilly and Company (LLY) swung to a profit in the fourth quarter from a loss last year, helped by…
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of…
Gilead Sciences swings to profit in Q4, but misses estimates
Gilead Sciences (GILD) swung to a profit in the fourth quarter from a loss last year, helped by a plunge…
Earnings preview: Cardiovascular to drive Boston Scientific Q4 results
Boston Scientific Corporation (BSX) is set to report its fourth-quarter earnings results on Wednesday before the bell. The medical device…
Earnings preview: Medicare Advantage to drive Humana’s Q4 growth
The quarterly performance of healthcare companies will be closely watched this season, considering the hectic M&A activity the sector has…
Earnings Preview: New drugs to propel Eli Lilly forward
Eli Lilly and Company (LLY) is scheduled to report earnings results for the fourth quarter of 2018 on February 6,…
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a…